Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

Nature Medicine - Tập 17 Số 8 - Trang 952-960 - 2011
Changli Wei1, Shafic El Hindi1, Jing Li1, Alessia Fornoni1, Nelson Goes2, Junichiro Sageshima3, Dony Maiguel1, S. Ananth Karumanchi4, Hui‐Kim Yap5, Moin A. Saleem6, Qingyin Zhang7, Boris Nikolic2, Abanti Chaudhuri8, Pirouz Daftarian9, Eduardo Salido10, Armando Torres10, Moro Salifu11, Minnie Sarwal8, Franz Schaefer12, Christian Morath13, Vedat Schwenger13, Martin Zeier13, Vineet Gupta1, David Roth1, Maria Pia Rastaldi14, George W. Burke3, Phillip Ruiz15, Jochen Reiser1
1Department of Medicine, Miller School of Medicine, University of Miami, Miami, Florida, USA
2Department of Medicine, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts, USA
3Department of Surgery, Miller School of Medicine, University of Miami, Miami, Florida, USA
4Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA
5Department of Pediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore
6University of Bristol, Children's Renal Unit, Bristol Royal Hospital for Children, Bristol, UK
7Department of Surgery, Columbia University, New York, New York USA
8Department of Pediatrics, Stanford University, Stanford, California, USA
9The Wallace H. Coulter Center for Translational Research, Miller School of Medicine, University of Miami, Miami, Florida, USA
10Servicio de Nefrologia and Centre for Biomedical Research on Rare Diseases (CIBERER), Hospital Universitario de Canarias, Canary Islands, Spain
11Division of Nephrology, SUNY Downstate Medical Center, Brooklyn, New York, USA
12Center for Pediatric and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany
13Department of Nephrology and Endocrinology, University of Heidelberg, Heidelberg, Germany
14Renal Research Laboratory, Fondazione IRCCS Ospedale Maggiore Policlinico & Fondazione D’Amico per la Ricerca sulle Malattie Renali, Milan, Italy
15Department of Pathology, Miller School of Medicine, University of Miami, Miami, Florida, USA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Kitiyakara, C., Eggers, P. & Kopp, J.B. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am. J. Kidney Dis. 44, 815–825 (2004).

Baum, M.A. Outcomes after renal transplantation for FSGS in children. Pediatr. Transplant. 8, 329–333 (2004).

Senggutuvan, P. et al. Recurrence of focal segmental glomerulosclerosis in transplanted kidneys: analysis of incidence and risk factors in 59 allografts. Pediatr. Nephrol. 4, 21–28 (1990).

Hickson, L.J. et al. Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence. Transplantation 87, 1232–1239 (2009).

Ponticelli, C. & Glassock, R.J. Post-transplant recurrence of primary glomerulonephritis. Clin. J. Am. Soc. Nephrol. 5, 2363–2372 (2010).

Tryggvason, K., Patrakka, J. & Wartiovaara, J. Hereditary proteinuria syndromes and mechanisms of proteinuria. N. Engl. J. Med. 354, 1387–1401 (2006).

Mathieson, P.W. Proteinuria and immunity—an overstated relationship? N. Engl. J. Med. 359, 2492–2494 (2008).

Savin, V.J. et al. Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity. Transl. Res. 151, 288–292 (2008).

Hoyer, J.R. et al. Recurrence of idiopathic nephrotic syndrome after renal transplantation. J. Am. Soc. Nephrol. 12, 1994–2002 (2001).

Artero, M.L. et al. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis. Am. J. Kidney Dis. 23, 574–581 (1994).

Haas, M. et al. Plasma immunadsorption treatment in patients with primary focal and segmental glomerulosclerosis. Nephrol. Dial. Transplant. 13, 2013–2016 (1998).

Kemper, M.J., Wolf, G. & Muller-Wiefel, D.E. Transmission of glomerular permeability factor from a mother to her child. N. Engl. J. Med. 344, 386–387 (2001).

Glassock, R.J. Circulating permeability factors in the nephrotic syndrome: A fresh look at an old problem. J. Am. Soc. Nephrol. 14, 541–543 (2003).

Savin, V.J. et al. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis. N. Engl. J. Med. 334, 878–883 (1996).

Sharma, M., Sharma, R., McCarthy, E.T. & Savin, V.J. “The FSGS factor”: enrichment and in vivo effect of activity from focal segmental glomerulosclerosis plasma. J. Am. Soc. Nephrol. 10, 552–561 (1999).

Bruneau, S. et al. Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation. Am. J. Kidney Dis. 54, 522–532 (2009).

McCarthy, E.T., Sharma, M. & Savin, V.J. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin. J. Am. Soc. Nephrol. 5, 2115–2121 (2010).

Wei, C. et al. Modification of kidney barrier function by the urokinase receptor. Nat. Med. 14, 55–63 (2008).

Blasi, F. & Carmeliet, P. uPAR: A versatile signaling orchestrator. Nat. Rev. Mol. Cell Biol. 3, 932–943 (2002).

Smith, H.W. & Marshall, C.J. Regulation of cell signaling by uPAR. Nat. Rev. Mol. Cell Biol. 11, 23–36 (2010).

Sier, C.F. et al. The level of urokinase-type plasminogen activator receptor is increased in the serum of ovarian cancer patients. Cancer Res. 58, 1843–1849 (1998).

Sidenius, N. et al. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 96, 4091–4095 (2000).

Young, B.C., Levine, R.J. & Karumanchi, S.A. Pathogenesis of preeclampsia. Annu. Rev. Pathol. 5, 173–192 (2010).

Ploug, M. & Ellis, V. Structure-function relationship in the receptor for urokinase-type plasminogen activator. Comparison to other members of the Ly-6 family and snake venom a-neurotoxins. FEBS Lett. 349, 163–168 (1994).

Kristensen, P., Eriksen, J., Blasi, F. & Dano, K. Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract. J. Cell Biol. 115, 1763–1771 (1991).

Hada, Y. et al. Selective purification and characterization of adiponectin multimer species from human plasma. Biochem. Biophys. Res. Commun. 356, 487–493 (2007).

D'Alessio, S. & Blasi, F. The urokinase receptor as an entertainer of signal transduction. Front. Biosci. 14, 4575–4587 (2009).

Selleri, C. et al. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. Cancer Res. 66, 10885–10890 (2006).

Pampori, N. et al. Mechanisms and consequences of affinity modulation of integrin αVβ3 detected with a novel patch-engineered monovalent ligand. J. Biol. Chem. 274, 21609–21616 (1999).

Honda, S. et al. Topography of ligand-induced binding sites, including a novel cation-sensitive epitope (AP5) at the amino terminus, of the human integrin beta 3 subunit. J. Biol. Chem. 270, 11947–11954 (1995).

Saleem, M.A. et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J. Am. Soc. Nephrol. 13, 630–638 (2002).

Zaidel-Bar, R., Ballestrem, C., Kam, Z. & Geiger, B. Early molecular events in the assembly of matrix adhesions at the leading edge of migrating cells. J. Cell Sci. 116, 4605–4613 (2003).

Mundel, P. et al. Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J. Cell Biol. 139, 193–204 (1997).

Ghiggeri, G.M., Carraro, M. & Vincenti, F. Recurrent focal segmental glomerulosclerosis in the era of genetics of podocyte proteins: theory and therapy. Nephrol. Dial. Transplant. 19, 1036–1040 (2004).

Dekkers, P.E., ten Hove, T., te Velde, A.A., van Deventer, S.J. & van Der Poll, T. Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia. Infect. Immun. 68, 2156–2160 (2000).

Crowley, S.D. et al. Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis. J. Clin. Invest. 119, 943–953 (2009).

Hoyer, J.R. et al. Recurrence of idiopathic nephrotic syndrome after renal transplantation. Lancet 2, 343–348 (1972).

Gohh, R.Y. et al. Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients. Am. J. Transplant. 5, 2907–2912 (2005).

Beck, L.H. Jr. et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med. 36, 11–21 (2009).

Clement, L.C. et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat. Med. 17, 117–122 (2011).

Zhang, S.Y. et al. c-mip impairs podocyte proximal signaling and induces heavy proteinuria. Sci. Signal. 18, ra39 (2010).

Einecke, G. et al. A molecular classifier for predicting future graft loss in late kidney transplant biopsies. J. Clin. Invest. 120, 1862–1872 (2010).

Vijayan, K.V., Goldschmidt-Clermont, P.J., Roos, C. & Bray, P.F. The PIA2 polymorphism of integrin β3 enhances outside-in signaling and adhesive functions. J. Clin. Invest. 105, 793–802 (2000).

Salido, E. et al. The polymorphism of the platelet glycoprotein IIIA gene as a risk factor for acute renal allograft rejection. J. Am. Soc. Nephrol. 10, 2599–2605 (1999).

Chiras, T. et al. Platelet GPIIIa polymorphism HPA-1 (PLA1/2) is associated with hypertension as the primary cause for end-stage renal disease in hemodialysis patients from Greece. In Vivo 23, 177–181 (2009).

Marszal, J. & Saleem, M.A. The bioactivity of plasma factors in focal segmental glomerulosclerosis. Nephron Exp. Nephrol. 104, e1–e5 (2006).

Tjwa, M. et al. Membrane-anchored uPAR regulates the proliferation, marrow pool size, engraftment, and mobilization of mouse hematopoietic stem/progenitor cells. J. Clin. Invest. 119, 1008–1018 (2009).

Thông tin
Thông tin xuất bản

Nature Medicine

Tập 17 Số 8

952-960

Thông tin tác giả